Analysis: Ventria on ITC win barring rHSA products

03-11-2022

Sarah Speight

Analysis: Ventria on ITC win barring rHSA products

shutterstock_2183917051_T. Schneider

Last month, October 2022, the US International Trade Commission (ITC) affirmed an administrative law judge’s (ALJ’s) finding that products containing recombinant human serum albumins (rHSAs) made by a Chinese company infringe a patent belonging to Ventria Bioscience.


Ventria, Healthgen, Husch Blackwell, Hovey Williams, patents, ITC, ALJ, US

LSIPR